Purchase and Installation of Brand Name of illumina NextSeq 1000 system (MDL#20038898) at Camp Zama, Zama-shi, Kanagawa Japan
ID: FA520924Q0071Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE AIR FORCEFA5209 374 CONS PKAPO, AP, 96328-5228, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/d384f05d30f34a5ab84c2ef3d3108711/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Air Force, is seeking a contractor for the purchase and installation of an Illumina NextSeq 1000 Sequencing System at Camp Zama, Zama-shi, Kanagawa, Japan. The procurement includes the delivery of the system to Building 715, on-site bilingual training in English and Japanese, and compliance with specific operational protocols as outlined in the governing Class Deviation 2018-O0019. This advanced sequencing system is critical for pathogen detection and characterization, aligning with the Defense Health Agency's laboratory protocols and enhancing public health surveillance capabilities. Interested parties must submit their offers by September 17, 2024, and can direct inquiries to Makoto Uchino or Keiko Osawa at the provided contact information.

    Files
    Title
    Posted
    1 Solicitation - FA520924Q0071.pdf
    The document outlines the solicitation for the procurement of an Illumina NextSeq 1000 Sequencing System, as part of a Women-Owned Small Business (WOSB) initiative. It specifies a requisition number, contract details, offer due date, and contact information for inquiry. The main item involves a single set of sequencing systems, including installation and bilingual training, to be delivered to the Environmental Molecular Biology Laboratory in Japan. Delivery instructions underscore a firm-fixed price arrangement with a 60-day period for delivery post-award. The contractor is required to comply with various federal procurement regulations, specifically regarding electronic invoicing through the Wide Area Workflow (WAWF) system. Additionally, specific clauses regarding taxes, dispute resolution, and unique identification of items delivered are included. Overall, the document serves as a formal request for bids, ensuring adherence to regulations while promoting participation from women-owned businesses, and emphasizes the importance of detailed documentation, proper handling, and compliance with procurement standards.
    2 Atch1 Spec for Nextseq-1000.pdf
    The document outlines the specifications and features of the NextSeq™ 1000 and NextSeq 2000 Sequencing Systems, developed by Illumina, designed for next-generation sequencing (NGS) applications in research. Key features include a streamlined workflow powered by advanced XLEAP-SBS chemistry, enhanced data quality, and integrated DRAGEN secondary analysis for efficient data processing. The systems boast a broad range of applications, from oncology to microbiome research, allowing scalability from small to large batches with high data quality. The NextSeq 2000 offers increased throughput, with specifications for various read lengths and flow cell configurations, optimizing both speed and cost-efficiency for diverse genomic studies. User-friendly integrated software options facilitate local and cloud-based data analysis, enhancing laboratory productivity. Illumina emphasizes its commitment to innovation and customer support, providing comprehensive post-purchase services, including a warranty and proactive maintenance solutions. This document serves as a detailed solicitation for government and institutional procurement, highlighting the capabilities and operational advantages of the NextSeq systems for advancing research objectives in genomics.
    3 Atch2 Class_Deviation_2018-O0019.pdf
    The document outlines the Class Deviation 2018-O0019, which governs the management of contractor personnel while performing tasks in Japan under the U.S. Armed Forces. It specifies definitions, including the terms of SOFA (Status of Forces Agreement) and the roles of contractors, dependents, and relevant military commands. Key requirements include compliance with U.S. and Japanese laws, background checks, appropriate documentation, and adherence to specific operational protocols such as logistical support and security plans. Contractors must ensure personnel possess valid Letters of Authorization (LOA) and comply with import regulations on weapons. Violations may result in prosecution by either U.S. or Japanese authorities, emphasizing the need for contractors to be familiar with obligations related to conduct, employment rights, and reporting mechanisms for wrongdoing. The document also highlights operational and evacuation procedures, as well as the responsibilities of contractors toward their personnel regarding medical and casualty support. Overall, it represents a framework ensuring effective deployment and management of contractor personnel in Japan, enhancing cooperation between U.S. military operations and host nation regulations.
    4 BNJ 24Q063A.pdf
    This Memorandum for Record outlines the justification for a single source acquisition under the Simplified Acquisition Threshold for the NEXT SEQ 1000 System, specifically requested by EMBL at the Public Health Command-Pacific, Camp Zama. According to FAR 13.106-1(b)(1)(i), the Contracting Officer may solicit from one source if only one is reasonably available due to unique conditions such as urgency or proprietary rights. The Illumina NEXT SEQ 1000 System is necessary for detecting and characterizing pathogens with precision and consistency, as it aligns with standardized laboratory protocols used across the Defense Health Agency's network. The acquisition is deemed a single-source requirement due to exclusive licensing agreements and the need for compatible equipment that produces reliable results in disease surveillance, critical for safeguarding public health. The Contracting Officer has determined that circumstances justify this procurement without competition. This document reflects the emphasis on rapid and efficient procurement in urgent health-related contexts within government operations.
    Spec for Nextseq1000.pdf
    The NextSeq 1000 and NextSeq 2000 Sequencing Systems by Illumina represent an advanced solution in next-generation sequencing (NGS), designed to enhance the scope of biological research while optimizing workflow efficiency. These benchtop platforms use innovative XLEAP-SBS chemistry, promising faster and more accurate sequencing with data outputs from 10 Gb to 540 Gb across various applications, including oncology and microbiome studies. Key features include an intuitive load-and-go operation, integrated onboard DRAGEN for secondary analysis, and a wide array of compatible library preparation kits supporting diverse read lengths. The systems facilitate brisk turnaround with a streamlined analysis capable of generating results within two hours, significantly reducing analysis bottlenecks. Illumina's comprehensive support model ensures technical assistance and system maintenance, enhancing customer experience and operational longevity. Designed for both local and cloud-based analysis, the systems align with contemporary research needs, offering scalability and flexibility for evolving scientific inquiries. In the context of government RFPs and funding, this technology showcases a commitment to fostering advanced research capabilities and productivity, fundamental to fulfilling diverse scientific objectives and substantiating compliance with regulatory standards.
    Similar Opportunities
    Medical Sysmex Reagents and Microbiological Media Plates
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting market research to identify local sources for the procurement and delivery of medical laboratory reagents and microbiological media plates in support of the United States Naval Hospital (USNH) located in Okinawa, Japan. This sources sought announcement aims to gather information on potential suppliers capable of fulfilling a requirement for Class VIII medical supplies, which are critical for laboratory diagnostics and healthcare operations. The anticipated contract will be a Firm-Fixed Price Indefinite Delivery, Indefinite Quantity type, with a base period of 12 months and one option period, estimated under $250,000, inclusive of shipping and delivery. Interested parties must submit their responses by 12:00 pm JST on October 13, 2024, to the designated contacts, Mamiko Jackson and Arlene Renner, via email.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Biomerieux Japan Ltd. for the supply of specific VITEK 2 test cards and annual preventive maintenance services for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The procurement includes a delivery schedule spanning fiscal years 2025 to 2027, detailing quantities for three types of test cards essential for laboratory analyses, along with maintenance for two Vitek 2 Compact Analyzers. This contract is critical for ensuring effective healthcare delivery to U.S. Forces Japan personnel, and interested vendors may submit technical capability statements by 07:00 a.m. Pacific Time on 23 September 2024, to Raphael Badagbor at raphael.k.badagbor.civ@health.mil, as no competitive proposals will be solicited.
    Quantum SI Platinum Instrument
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Health Research Center (NHRC), is seeking quotes for the procurement of a Quantum SI Platinum Instrument and associated items, under a total small business set-aside contract. The procurement includes a Quantum SI Platinum Instrument, an Advanced Next-Generation Protein Sequencing Training session, and various sequencing and library preparation kits, all intended for laboratory use in San Diego, California. These items are critical for ongoing studies and must be delivered promptly, with specific delivery schedules outlined for the kits. Interested vendors must register with the System for Award Management (SAM) and provide detailed quotes by referencing solicitation number N63116-25-Q-0501. For further inquiries, vendors can contact David L. Hill at (619) 767-4901 or via email at david.l.hill4.civ@health.mil.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting a sources sought announcement to identify local sources capable of providing medical laboratory reagents for the United States Naval Hospital (USNH) in Okinawa, Japan. The procurement involves the delivery of CLASS VIII medical laboratory reagents, including Ortho reagents and consumables compatible with VITROS 5600 Analyzers, along with necessary training and maintenance services for the equipment. This opportunity is critical for ensuring the availability of essential medical supplies and maintaining compliance with healthcare standards in a military setting. Interested parties must submit their qualifications and relevant information by September 30, 2024, to the primary contacts, Bradley Ah Nee and Arlene Renner, via email at bradley.ahnee@dla.mil and arlene.renner@dla.mil, respectively. The estimated contract value is under $5.4 million, covering a base period of 12 months with two optional periods.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to acquire comprehensive clinical whole genome sequencing services, including interpretation and reporting, to enhance the understanding of infectious diseases and improve patient care, with a focus on delivering results within a four-week turnaround time. This initiative is critical for advancing clinical research and understanding the genetic basis of diseases, as the NIAID conducts numerous clinical trials annually. Interested vendors must submit their quotes by September 23, 2024, and direct any inquiries to Seth Schaffer at seth.schaffer@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Microbiology Supplies and Reagents at U.S. Naval Hospital Guam
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified small businesses to provide microbiology supplies and reagents for the U.S. Naval Hospital in Guam. The procurement includes essential quality controls and reagents necessary for laboratory testing operations, with a delivery period from October 1, 2024, to September 30, 2025, and options for four additional years. This acquisition is critical for maintaining public health and ensuring reliable access to diagnostic tools within the military healthcare system. Interested contractors must submit their quotes electronically by 9:00 AM PDT on September 19, 2024, and can direct inquiries to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil.
    6515--FY25: Automated Nucleic Acid Extraction System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide an Automated Nucleic Acid Extraction System as part of a Sources Sought Notice under solicitation number 36C24824Q1656. The system must be fully automated, capable of efficiently extracting high-quality DNA and RNA from various specimen types, including formalin-fixed paraffin embedded tissues, while demonstrating superiority in extraction methods for next-generation sequencing applications. This procurement is crucial for enhancing laboratory capabilities within the VA, ensuring high throughput processing and compatibility with multiple extraction kits, all while adhering to standard laboratory benchtop dimensions. Interested parties must submit their responses, including company information and a capability statement, by September 24, 2024, to Contract Specialist Benjamin Amato at benjamin.amato@va.gov.
    Luminex 200
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Submarine Medical Research Laboratory (NSMRL), is seeking proposals for the procurement of a Luminex 200 Instrument System, which is essential for conducting antibody and RNA transcript analyses. This advanced analytical equipment will enable NSMRL to perform in-house biochemical analyses, facilitating the simultaneous detection of multiple proteins and gene expression, thereby improving the health and performance of Navy divers and submariners by addressing risks associated with oxygen toxicity and decompression stress. Interested contractors must submit their proposals by 8:00 AM on September 20, 2024, including detailed pricing and compliance with federal regulations, with a total funding amount of $63,000 for this sole source procurement from Thermofisher Scientific. For further inquiries, interested parties should contact Jessica Lindner at jessica.c.lindner2.civ@us.navy.mil.